Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether
about
Ongoing challenges in the management of malariaThe clinical efficacy of artemether/lumefantrine (Coartem)Revisiting the basic reproductive number for malaria and its implications for malaria controlChlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malariaStrong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trialArtemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malariaArtemether-lumefantrine (four-dose regimen) for treating uncomplicated falciparum malariaThe benefits of artemisinin combination therapy for malaria extend beyond the individual patientEffect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South AfricaRolling back a malaria epidemic in South Africa.Blocking malaria transmission to Anopheles mosquitoes using artemisinin derivatives and primaquine: a systematic review and meta-analysisNovel strategies lead to pre-elimination of malaria in previously high-risk areas in Suriname, South AmericaGametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient dataChloroquine/sulphadoxine-pyrimethamine for gambian children with malaria: transmission to mosquitoes of multidrug-resistant Plasmodium falciparumRandomised trial of chloroquine/sulphadoxine-pyrimethamine in Gambian children with malaria: impact against multidrug-resistant P. falciparumRapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial useGametocytaemia after drug treatment of asymptomatic Plasmodium falciparumPrimaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunateSafety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina FasoModelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensityMosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriersTargeting asymptomatic malaria infections: active surveillance in control and eliminationHIV-positive nigerian adults harbor significantly higher serum lumefantrine levels than HIV-negative individuals seven days after treatment for Plasmodium falciparum infection.Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.Plasmodium falciparum antigens on the surface of the gametocyte-infected erythrocyteComparing highly efficacious antimalarial drugs.Screening of traditionally used plants for in vivo antimalarial activity in mice.Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?Transmission and cross-mating of high-level resistance Plasmodium falciparum dihydrofolate reductase haplotypes in The GambiaTransmission blocking activity of a standardized neem (Azadirachta indica) seed extract on the rodent malaria parasite Plasmodium berghei in its vector Anopheles stephensiFive years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique.In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individualsMalaria gametocytogenesis.Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.Monitoring, characterization and control of chronic, symptomatic malaria infections in rural Zambia through monthly household visits by paid community health workersA review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmissionReduced risk of malaria parasitemia following household screening and treatment: a cross-sectional and longitudinal cohort studyEpidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and eliminationThe effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: an open-label, randomized, controlled trial.
P2860
Q17485687-626D8C88-DE2E-421D-B968-9B7B0663D3ECQ21034141-C334C6C5-00A9-418B-83F4-7471E925076EQ21090219-FC57A937-66B7-47D1-A998-39CB536E7259Q21143739-61BC9152-E39E-45C6-9176-CD3F56211E72Q21562479-818C7D9A-DBD3-4849-B511-9683ECAEAE65Q24245437-DD772E9A-18B9-4B28-9511-F12E68D7D50EQ24246332-EE1CF8AE-3B52-4D2A-86E9-4CD9E5F5BAC5Q24792313-2949501B-F303-4736-BB02-F102BABDCD36Q24810617-03BF41E0-1D8D-40E5-A87D-5440D9F2E207Q24810656-5A8EFBC9-AFFE-4A5A-8B4A-AC1D23261A83Q27014789-5C5EB98B-15A2-4A06-80C5-9AB7C0D14EE1Q27497222-BB061666-DF4A-4D0D-BAD2-40DC8CD82859Q28068072-37500124-7A6E-4CE8-8E6D-7837AB43FA53Q28469025-41439115-E5DC-4A0B-9359-95733B830F32Q28469026-1072C427-2711-438B-9D97-0F6A386F7B7CQ28469104-F0AEDDCE-6E00-41BC-A0A6-DAB4DB95AB32Q28469180-32990F52-CA83-4FB5-B2A9-4CA6D1DBC8AAQ28469316-2C82CBDF-362D-4B36-B435-BB2A998921E9Q28472182-486AA6AB-7E57-462E-9834-B7F068940E82Q28474141-AC9DDFBA-063E-4366-AEB2-0E4D0B02ACE1Q28482471-7977BA34-6D57-42F4-9A4F-DF6A93C65CE3Q28534608-0F5ED840-D2E6-4397-B726-AD24E51B3CF5Q30392186-FC0ED639-C8BA-4242-83E9-EE135DFAC125Q33251914-34F99E5C-E262-4E37-A800-161560D7E909Q33338492-F3D8C59E-AD46-4D9C-BAB0-5B6C5E8D092EQ33385481-7EB7179D-75F7-4669-B1EA-38F2C4EB950EQ33630564-6871233B-7825-44E6-B66F-032DB8C21F6BQ33635019-F5B4E9E7-DA9F-4330-B97F-3FA2510D4FA6Q33670134-11F1CBAD-55C0-47A3-94D9-66DB4442C11EQ33749694-80DCA2F0-0B8C-4C16-BF41-0E26824FB869Q33759036-1559449E-2748-4164-9928-90E98DA4EF2AQ33817503-C4B833CA-FC16-4B95-A0A5-BC9FEE69B808Q33826283-1FB4A945-DB14-42A7-937F-A197BBA7999EQ33894262-69992C64-2130-423E-9EBE-221706B3599DQ33898575-8D92DD6E-49E0-4561-AE0E-24A0D9254D29Q33960088-DCBA5CDE-CBF9-4154-971F-199125C1DE5AQ34020818-2E8CD89A-B6DA-467F-B7A6-1E55F405F336Q34154816-890CA57D-404F-48F2-BD45-25DC5557EC3EQ34177472-86CCCDA3-6B5E-4DC4-A9FC-D02E5223D117Q34486508-E0653EB3-6DD7-4674-8DB8-6F39A6EBB992
P2860
Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Reduction of malaria transmiss ...... -dose regimen of co-artemether
@ast
Reduction of malaria transmiss ...... -dose regimen of co-artemether
@en
Reduction of malaria transmiss ...... -dose regimen of co-artemether
@nl
type
label
Reduction of malaria transmiss ...... -dose regimen of co-artemether
@ast
Reduction of malaria transmiss ...... -dose regimen of co-artemether
@en
Reduction of malaria transmiss ...... -dose regimen of co-artemether
@nl
prefLabel
Reduction of malaria transmiss ...... -dose regimen of co-artemether
@ast
Reduction of malaria transmiss ...... -dose regimen of co-artemether
@en
Reduction of malaria transmiss ...... -dose regimen of co-artemether
@nl
P2093
P2860
P3181
P1433
P1476
Reduction of malaria transmiss ...... -dose regimen of co-artemether
@en
P2093
Christopher J Drakeley
Colin J Sutherland
Geoffrey A T Targett
Musa Jawara
Neal Alexander
Rosalind Coleman
Rosalynn Ord
P2860
P3181
P356
10.1371/JOURNAL.PMED.0020092
P407
P577
2005-04-01T00:00:00Z